10 Best Value Dividend Stocks to Buy According to Billionaires

8. McKesson Corporation (NYSE:MCK)

Number of Billionaire Holders: 16

Forward P/E Ratio as of April 13: 18.80

McKesson Corporation (NYSE:MCK) is a Texas-based healthcare company that specializes in pharmaceutical distribution and offers health information technology, medical supplies, and health management solutions. In recent years, the company has streamlined its focus on its core markets in the US and Canada, stepping away from certain European regions to better allocate its resources. The company’s strength lies in its extensive distribution network and strong relationships with both customers and suppliers, allowing it to operate efficiently and offer broad services within pharmaceutical distribution.

In its fiscal Q3 2025, McKesson Corporation (NYSE:MCK) posted a revenue of $95.3 billion, marking an 18% year-over-year increase. Adjusted operating profit rose by 16% to $1.5 billion. Despite the strong performance, revenue came in slightly below analysts’ expectations of $96.08 billion, with softer results in the US pharmaceutical segment contributing to the shortfall. The stock has a forward P/E of 18.80, which makes it one of the best value stocks to invest in.

In response to its solid results, McKesson Corporation (NYSE:MCK) raised its full-year adjusted earnings forecast to between $32.55 and $32.95 per share, reflecting an expected annual growth of 19% to 20%. The company also emphasized its ongoing commitment to shareholder returns, having distributed $3.1 billion in the first nine months of 2024, including $254 million in dividends. It currently pays a quarterly dividend of $0.71 per share and has a dividend yield of 0.41%, as of April 13. The company has raised its payouts for eight consecutive years.